# Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment

> **NCT02982603** · PHASE4 · COMPLETED · sponsor: **Dongzhimen Hospital, Beijing** · enrollment: 350 (actual)

## Conditions studied

- Mild Cognitive Impairment
- Herbal Medicine Allergy

## Interventions

- **DRUG:** Qinggongshoutao Bolus
- **DRUG:** Ginkgo Biloba Extract 761
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT02982603
- **Lead sponsor:** Dongzhimen Hospital, Beijing
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02982603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02982603, "Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02982603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*